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Background: The Hispanic population represents the fastest growing minority in the United States. As the population
grows and ages, the vascular surgery community will be providing increasing amounts of care to this diverse group. To
appropriately administer preventive and therapeutic care, it is important to understand the incidence, risk factors, and
natural history of vascular disease in Hispanic patients.
Methods: We analyzed hospital discharge databases from New York and Florida to determine the rate of lower extremity
revascularization (LER), carotid revascularization (CR), and abdominal aortic aneurysm (AAA) repair in Hispanics
relative to the general population. The rates of common comorbidities, the indications for the procedures, and outcomes
during the same hospitalization as the index procedure were determined. Multivariate logistic regression analysis was
used to determine the differences between Hispanics and white non-Hispanics with respect to rate of procedure,
symptoms at presentation, and outcome after procedure. Demographic variables and length of stay were also analyzed.
Results. The rate of LER, CR, and AAA repair was significantly lower in Hispanic patients than in white non-Hispanics.
Despite this lower rate of intervention, Hispanics were significantly more likely than whites to present with limb-
threatening lower extremity ischemia (odds ratio [OR], 2.09; 95% confidence interval [CI], 1.91 to 2.29), symptomatic
carotid artery disease (OR, 1.57; 95% CI, 1.4 to 1.75), and ruptured AAA (OR, 1.26; 95% CI, 1.04-1.52) than white
non-Hispanics These differences were maintained after controlling for the presence of diabetes mellitus and other
comorbidities. Hispanic patients had higher rates of amputation during the same hospitalization after LER (6.2% vs 3.4%,
P < .0001) and higher mortality after elective AAA repair (5% vs 3.4%, P  .0032). Length of stay after LER, CR, and
AAA repair was longer for Hispanic patients than white non-Hispanics.
Conclusion: Significant disparities in the rate of utilization of three common vascular surgical procedures exist between
Hispanic patients and the general population. In addition, Hispanics appear to present with more advanced disease and
have worse outcomes in some cases. Reasons for these disparities must be determined to improve these results in the
fastest growing segment of our society. ( J Vasc Surg 2007;46:971-8.)Hispanics are the fastest growing minority in the
United States (US), and are estimated to comprise one-
quarter of the total US population by 2050.1,2 Numer-
ous public health studies have demonstrated the exis-
tence of substantial health disparities in this population,
including higher rates of breast arterial calcification,
diabetes mellitus, and renal failure, as well as an increased
risk of death from prostate cancer and liver disease.3-8
Previous research has shown that distinctive biologic,
socioeconomic, and cultural factors may have an impact
on the treatment and outcomes of vascular disease.2,9-11
Therefore, understanding the health issues that uniquely
impact Hispanics is essential to provide the appropriate
combination of preventive, diagnostic, and therapeutic
modalities to these patients.
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doi:10.1016/j.jvs.2007.07.021Despite the well-documented rising prevalence in
Hispanics of risk factors for vascular disease, such as
diabetes and smoking, studies that focus on treatment
and outcomes of vascular disease in this population are
lacking. In this study, we aimed to determine, through
large data set analysis, if differences exist between His-
panics and the general population with respect to the rate
of treatment and clinical manifestations of common vas-
cular diseases.
METHODS
Data sources. Publicly available hospital discharge
data bases obtained from New York State Health Depart-
ment, the Statewide Planning and Research Cooperative
System (SPARCS),12 and the Florida state Agency for
Healthcare Administration,13 years 2000-2004, were
used in the study. These are populous states with a
substantial presence of Hispanics. State administrative
databases contain clinical and demographic information,
including ethnicity, associated with each hospital dis-
charge.
Patient population. Patients were selected using the
International Classification of Diseases, 9th Revision,
Clinical Modification (ICD-9-CM) procedure and diag-
noses codes, as described earlier.14,15 Treatment groups
were identified by matching all relevant procedure codes
971
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code groups were analyzed: carotid revascularizations
(CR), elective and ruptured abdominal aortic aneurysm
(AAA) repair, lower extremity revascularizations (LER),
and lower limb amputation. Patients undergoing AAA
repair were categorized as 441.4 (unruptured) or 441.3
(unruptured). Patients who underwent carotid proce-
dures were divided into symptomatic and asymptomatic
groups:
● Symptomatic patients were those who presented
with the following diagnoses (primary or any sec-
ondary positions): 433.11 (occlusion and stenosis of
carotid artery with cerebral infarction), 433.31 (oc-
clusion and stenosis of multiple and bilateral arteries
with cerebral infarction), 435.9 (unspecified tran-
sient cerebral ischemia), 362.3 (retinal vascular oc-
clusion), and 362.84 (retinal ischemia).
● Asymptomatic patients were those who presented
with the diagnoses in the primary or any secondary
positions of 433.10 and 433.30 (occlusion and ste-
nosis of carotid and multiple and bilateral arteries
without mention of cerebral infarction, respec-
tively). If symptomatic and asymptomatic diagnoses
were present in the same discharge summary, pa-
Table I. List of International Classification of Diseases, 9t
postoperative complications
Comorbidities ICD9-CM code
Diabetes 250 Di
Hypertension 401 Es
402 H
403 H
404 H
405 Se
Emphysema 490 Br
491 Ch
492 Em
493 As
494 Br
496 Ch
Coronary 413 An
414 O
412 O
429.2 Ca
Peripheral 443.9 Pe
440 At
Renal 585 Ch
403 H
582 Ch
Cerebral 434 O
433 O
437 O
438 La
Lipids 272.0 Di
Hypotension 458.2 H
458.8 O
458.9 H
ICD-9CM, International Classification of Diseases, 9th revision, Clinical Mtients were included in the symptomatic group.Patients who underwent LER with diagnoses of rest
pain (440.22), ulceration (440.23 or 707.1), and gan-
grene (440.24 or 785.4) were included in the limb-
threatening conditions group and were compared with
patients who had diagnoses of claudication (440.21). If
LER and major amputation were performed during the
same hospitalization, these cases were considered as
failed LER.
We assessed the following comorbidities (primary
and all secondary diagnosis): diabetes, hypertension, em-
physema, coronary disease, peripheral vascular disease,
renal disease, cerebrovascular disease, and lipid metabo-
lism disorder. Complications included (primary and all
secondary diagnosis) cardiac, postoperative stroke, respi-
ratory complications, bleeding, infection, shock, acute
renal failure, and mesenteric infarction. Table I outlines
the codes used to determine comorbidities and compli-
cations. A list of ICD9 diagnosis codes for comorbidities
and complications is provided in our earlier publica-
tions.14,15
Standardization. The risk of developing vascular
diseases and consequently undergoing a vascular proce-
dure varies across the age groups. We used direct adjust-
ment procedures to account for age and gender differ-
ision, Clinical Modification codes for comorbidities and
Code description
s mellitus
l hypertension
nsive heart disease
nsive renal disease
nsive heart and renal disease
ary hypertension
itis, not specified as acute or chronic
bronchitis
ema
iectasis
airway obstruction, not elsewhere classified
pectoris
orms of chronic ischemic heart disease
ocardial infarction
ascular disease, unspecified
ral vascular disease, unspecified
clerosis
renal failure
nsive renal disease
glomerulonephritis with unspecified pathologic lesion in kidney
on of cerebral arteries
on and stenosis of precerebral arteries
nd ill-defined cerebrovascular disease
ect of cerebrovascular disease
r of lipoid metabolism. Pure hypercholesterolemia
nsion. Iatrogenic hypotension
pecified hypotension
nsion, unspecified
ation.h rev
abete
sentia
yperte
yperte
yperte
cond
onch
ronic
phys
thma
onch
ronic
gina
ther f
ld my
rdiov
riphe
heros
ronic
yperte
ronic
cclusi
cclusi
ther a
te eff
sorde
ypote
ther s
ypoteences among Hispanics and white non-Hispanics
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and to ensure a proper comparison.16 Age and gender
distribution by race for New York and Florida pop-
ulations were obtained from National Census Bureau
(www.census.gov). The 2000 Florida WnH population
was chosen as the standard population. We identified the
number of vascular procedures and calculated rates for
the following age groups of Hispanics and WnH of both
sexes: 15, 14 to 44, 45 to 54, 55 to 64, 65 to 74, 75 to
84, and 85 years. The age and gender adjusted rates
were calculated by applying the age-specific and gender-
specific rates to the standard population and dividing by
the total in the standard population. By this type of
adjustment, we removed possible confounding caused by
age and gender variation. Rates adjusted for age and
gender were presented as the number of vascular proce-
dures per 10,000 standard population.
Statistical analysis. Statistical analysis was per-
formed using SAS software (SAS Institute Inc, Cary,
NC). Means were compared with the Student t test, and
proportions were analyzed using the 2 test. Statistical
significance was expressed as P values and 95% confi-
dence intervals (CIs). CIs for proportions were calcu-
lated using normal approximation to the binomial distri-
bution. Multivariate logistic regression analysis was used
to analyze risk factors for severity of disease at presenta-
tion and outcomes after intervention. The variables an-
alyzed are summarized in Table II. Results of the multi-
variate logistic regression are presented as odds ratios
(ORs) with the appropriate 95% CIs.
RESULTS
Rates of utilization. Utilization of vascular proce-
dures differed substantially between Hispanics and WnH
during the period from 2000 to 2004 (Fig 1). Hispanics
underwent significantly fewer LER procedures, AAA
repairs, and CR compared with WnHs throughout the 5
years analyzed. In contrast, major lower extremity am-
putations were more common among Hispanics than
WnHs. The magnitude of difference in rates of interven-
tion between Hispanics andWnHs was most dramatic for
AAA repair and CR, where WnHs had approximately
three times as many CR and AAA repairs than did
Table II. Comorbid conditions*
Condition
LER
WnH (%) H (%) P WnH
Diabetes 37.4 60.3 .0001 25
Hypertension 62.3 66.2 .0001 71
Renal 8.8 14.8 .0001 2
Coronary 42.9 39.1 .0001 42
Emphysema 23.1 16.4 .0001 17
Cerebral 6.7 5.9 .0358 99
Lipids 11.9 10.3 .0003 19
LER, Lower extremity revascularization; CR, carotid revascularization; AA
*See Table III for number of observations.Hispanics.Characteristics of patient populations. Hispanic
patients were significantly younger than WnHs, with the
largest difference seen among LER patients (2.6 years on
average; Table III). The relative proportion of women
and men in both groups was similar in LER and CR
patients, whereas there were more men among Hispanic
AAA patients and amputees. To gain further insight into
the cause of the different utilization of vascular proce-
dures, we analyzed the comorbidities affecting these
patients. Consistent with a body of evidence indicating a
high prevalence of diabetes mellitus type 2 in the His-
panic population, our data show a higher proportion of
CR AAA
H (%) P WnH (%) H (%) P
41.7 .0001 12.0 17.4 .0001
77.6 .0001 61.7 68.5 .0001
3.5 .0001 4.0 6.0 .0027
45.7 .0011 44.3 42.5 .3061
13.8 .0001 33.7 31.8 .2460
99.8 .6026 3.7 2.5 .0746
17.9 .0623 15.4 14.0 .2677
ctive abdominal aortic aneurysm; WnH, white non-Hispanic; H, Hispanic.
Fig 1. Rate of utilization of vascular procedures for Hispanics
(filled circles) and white non-Hispanics (WnH, clear circles), 2000-
2004. A, Lower extremity revascularization (LER). B, Carotid
revascularization (CR).C,Abdominal aortic aneurysm (AAA).D,
Major lower extremity amputation.(%)
.6
.0
.1
.8
.7
.9
.3
A, eleHispanic patients had diabetes compared with WnHs for
ation
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prevalent among Hispanic patients undergoing LER
(60.3%) and CR (41.7%) than among Hispanic patients
undergoing AAA repairs. In fact, these patients had less
diabetes (17.4%) than what has been reported for the
general Hispanic population aged 40 to 74 years. Hyper-
tension and renal disease also affected more patients
among Hispanics than among WnHs across all proce-
dures analyzed (Table II). WnHs undergoing LER
showed an increased prevalence of emphysema, coro-
nary, cerebral, and lipid metabolism complications than
did Hispanics; however, with the exception of emphy-
sema, these differences were not noted in patients receiv-
ing CR or AAA repairs.
Status of disease progression at time of treatment.
We analyzed potential differences in symptoms at the
time of treatment between WnHs and Hispanics. His-
panics were significantly more likely to present with
limb-threatening ischemia, symptomatic carotid artery
disease, and ruptured AAA than WnHs independent of
age, gender, and other comorbidities (Table IV). Be-
cause of the high prevalence of diabetes in Hispanics, we
specifically analyzed the relationship between diabetes
and disease status of patients undergoing lower extrem-
ity revascularizations. As expected, diabetes was associ-
ated with a higher rate of a limb-threatening condition,
including rest pain, ulceration, or gangrene, and less so
with claudication (Fig 2). When Hispanics and WnHs in
the diabetic and nondiabetic cohorts were compared,
however, more Hispanics presented with limb-threaten-
ing symptoms than did WnHs in both groups. Thus,
although Hispanics undergo significantly fewer interven-
tions for common arterial pathologies, they are more
Table III. Age and sex in Hispanic and white non-Hispan
Procedure
No. of observations
WnH H WnH
LER 66,633 5565 70.4
CR 85,038 3072 71.7
AAA (elective) 22,789 866 73.1
Major amputation 19,626 3260 71.3
WnH, White non-Hispanic; H, Hispanic; LER, lower extremity revasculariz
Table IV. Clinical manifestation of disease at the time of
Indication for procedure
Patients recei
WnH
Limb threatening ischemia 62.2 8
Symptomatic carotid disease 7.9 1
RAAA 11.0 1
OR, Odds ratio; CI, confidence interval; H, Hispanic; WnH, white non-Hi
Number of observations: lower extremity revascularization—WnH, 43,904
aortic abdominal aneurysm repairs—WnH, 25,632; Hispanics, 1004.likely than WnHs to present with advanced disease.Outcomes after intervention. We asked if vascular
procedures in Hispanic and WnH patients resulted in
different outcomes. Our data source limited the analysis
to outcomes occurring during the hospital admission for
the index treatment. Consistent with the more severe
symptom profile, our findings indicate that Hispanic
patients had significantly higher rates of major amputa-
tion after LER and deaths after elective AAA repair
(Table V). No significant differences were found in
postoperative stroke for patients undergoing CR. We
also found that for all procedures the hospital, length of
stay was longer for Hispanics than for WnHs, although
for AAA this difference was less dramatic (Table VI).
DISCUSSION
In this study we report major differences between
Hispanics and WnHs in the treatment and outcomes of
major vascular procedures. Evidence that ethnicity and
race are predictors of screening disparities, treatment
variations, and health outcomes has been reported in the
medical and surgical literature.17-22 Racial differences in
the utilization of surgical procedures have been seen in
joint replacements, myocardial revascularization, renal
transplant, and even dialysis access, with minorities more
likely than whites to have prosthetic arteriovenous grafts
vs primary fistulas.17-19 For lower extremity amputa-
tions,10,11,23-25 numerous publications have shown that
race-related differences exist in presentation and rates of
intervention. These differences are often attributed to
genetic variations, lack of screening, inferior access to
care and awareness, delayed intervention, and treatment
scular patients
e (mean) Sex (% of women)
H P WnH H P
67.8 .0001 41.9 42.7 .3177
70.2 .0001 41.7 40.1 .0775
71.6 .0001 19.9 15.8 .0031
69.1 .0001 44.5 40.6 .0001
; CR, carotid revascularization; AAA, elective abdominal aortic aneurysm.
ent
rocedure (%)
OR (95% CI) for H vs WnHP
.0001 2.09 (1.91-2.29)
.0001 1.57 (1.40-1.75)
.0179 1.26 (1.04-1.52)
; RAAA, ruptured abdominal aortic aneurysm.
anics, 3727; carotid revascularization—WnH, 85,038; Hispanics, 3072; allic va
Agtreatm
ving p
H
0.9
1.8
3.5
spanic
; Hispdiscrepancies.
iabet
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differences in the rate of utilization of major therapeutic
procedures did lessen significantly during the 1990s.
Our study detected significant differences in the rates of
Fig 2. Disease status of Hispanic (filled bars) and white
extremity revascularization (LER) in diabetic and non-d
Table V. Major outcomes within the same hospitalization
aneurysm and carotid revascularization procedures in Hisp
Major outcome
Patients receivin
WnH H
Amputations after LER 3.4 6.
Deaths after elective AAA 3.4 5
Stroke after CR 1.2 1.
WnH,White non-Hispanic;H,Hispanic; OR, odds ratio; CI, confidence in
CR, carotid revascularization.
*See Table III for number of observations.
Table VI. Length of stay of vascular patients receiving
lower extremity revascularization, carotid revascularization,
and abdominal aortic aneurysm repair*
Procedure WnH H P
LER
Mean 8 12.3 .0001
Median 5 8
CR
Mean 2.9 4.9 .0001
Median 2 2
AAA (elective)
Mean 7.5 8.6 .003
Median 6 6
WnH, White non-Hispanic; H, Hispanic; LER, lower extremity revascular-
ization; CR, carotid revascularization; AAA, elective abdominal aortic an-
eurysm.
*See Table III for number of observations.treatment of AAA, carotid artery disease, and lowerextremity arterial disease between Hispanic and WnH
patients. Having noted these disparities, attempts at
explaining them and reducing them represent the criti-
cally important aspect of this project.
Previous studies have shown an increased prevalence
of diabetes and renal insufficiency in Hispanics.7,8 Con-
sistent with these reports, we observed significantly
higher rates of diabetes and renal insufficiency in Hispan-
ics undergoing LER, AAA repair, and CR (Table II). A
possible confounding factor may be that diabetes is less
well controlled in Hispanics and therefore more severe
sequelae may be expected. This would explain why dia-
betes alone did not fully explain disparities we have
identified but could still be responsible for a significant
portion of the results we demonstrated. Higher rates of
diabetes may be related to biologic tendency or dietary
and socioeconomic factors.
Our data also showed a higher rate of hypertension,
a known risk factor for vascular disease, among Hispanics
(Table II). The Northern Manhattan Stroke Study dem-
onstrated an increased prevalence within the Hispanic
population of untreated and unrecognized hyperten-
-Hispanic (WnH, clear bars) patients undergoing lower
ic cohort.
r lower extremity revascularization, abdominal aortic
and white non-Hispanics*
procedure, %
OR (95%CI) for H vs WnHP
.00011 .67 (1.48-1.88)
.00321 .63 (1.18-2.27)
.47351 .12 (0.82-1.54)
LER, lower extremity revascularization; AAA, abdominal aortic aneurysm;nonafte
anics
g the
2
3
terval;sion.27,28 Therefore, efforts directed at detection and
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tant component of a strategy aimed at addressing vascu-
lar disease in Hispanics.
Socioeconomic factors may affect patients’ access to
proper preventive and diagnostic care. One survey de-
scribes Hispanics to have the highest reported uninsured
rate among all ethnic groups and to lack basic access to
medical care largely due to poor communication and
understanding between patient and physician.29 We be-
lieve insurance status may result in inferior access to
preventive and diagnostic care in Hispanic patients, thus
resulting in more advanced disease at the time of treat-
ment. Cigarette smoking, a well-known risk factor for
vascular disease, is lower among Hispanics than
WnHs.30,31 Although we have not specifically analyzed
this risk factor in our study, the lower rate among
Hispanics makes this factor less likely to be a confound-
ing variable in our analysis. Indeed, lower rates of to-
bacco abuse among Hispanics make our results appear
more dramatic with respect to ethnicity as a risk factor for
vascular disease.
With respect to lower extremity arterial disease, our
data indicate that Hispanic patients present with more
advanced limb ischemia and have higher rates of failed
LER and major amputation than WnHs (Fig 2, Tables IV
and V). Conversely, WnHs are more often treated for
claudication as the indication for LER.
With strong evidence demonstrating that Hispanics
have a higher prevalence of risk factors and comorbidities
well known to promote peripheral vascular disease, it
may seem appropriate to attribute the disparities discov-
ered in this analysis to modifiable and treatable risk
factors. However, Hispanic ethnicity remained associ-
ated with more advanced disease even after controlling
for coexisting comorbidities, including diabetes. Certain
socioeconomic factors such as lower level of education,
lack of insurance, and low income are more prevalent in
ethnic minorities and can potentially have a negative
effect on health outcomes.32-36 Moreover, many His-
panics traditionally rely on generations of self-care meth-
ods and are reluctant to seek professional treatment and
may even be less “willing” to consider prophylactic
surgical interventions.37-39 As a result, peripheral vascu-
lar disease may progress to later stages before treatment
is sought. It is also possible that there are genetic differ-
ences in the nature and manifestation of vascular disease
in Hispanics.
Our analysis shows that Hispanics have lower rates of
carotid intervention and presented more often with
symptomatic carotid disease, whereas WnHs are more
likely asymptomatic at the time of diagnosis (Table IV).
The reasons for an overall lower rate of carotid interven-
tion in Hispanics are unclear but may include a tendency
toward less plaque formation,40 which may result in less
extracranial disease. However, a higher incidence of
ischemic strokes of all etiologies has been previously
reported in Hispanics.41Our consistent finding of advanced symptomatology
at presentation among Hispanics may be partially due to
lower rates of screening for asymptomatic carotid dis-
ease. This result suggests that proper access to screening
and prophylactic intervention may significantly reduce
strokes in this population by allowing treatment of
asymptomatic patients. The paradox of lower interven-
tion rates but more advanced disease at time of treatment
suggests that a significant proportion of patients are not
detected when prophylactic treatment is most effective.
We have demonstrated that Hispanics undergo elec-
tive AAA repair much less frequently than WnHs. The
reasons for this finding are unclear, and published re-
ports addressing AAA in Hispanics are scarce. Diabetes
has been suggested as a negative predictor of AAA.42 An
interesting observation was a low rate of diabetes when
AAA repair was compared with LER and carotid inter-
vention, a finding that supports a possible negative asso-
ciation between these two entities (Table II). The higher
rate of diabetes among Hispanics may result in lower
rates of AAA and in part explain our observation of fewer
AAA repairs in this group. However, less access to
screening may also lead to lower detection of AAA and
hence fewer elective repairs.
Although Hispanics had significantly lower rates of
AAA repair, they were more likely to present with rup-
ture (Table IV). It is possible that Hispanics are less likely
to be diagnosed and treated before the AAA requires
urgent repair. Differences in disease presentation and
rates of disease progression are also a possible explana-
tion. The significant increase in the outcome of death
after elective AAA repair for Hispanic may be partially
attributed to the higher prevalence of renal failure in the
Hispanic population studied compared with WnHs (Ta-
bles II and V).43-46
Administrative databases are quite powerful because
of the amount of data they contain, but they have certain
inherent limitations. This analysis relies on the assump-
tion that ethnicity is reported accurately in the discharge
data. Errors in coding of comorbidities, risk factors, and
assignment of ethnicity are possible. The effects of such
limitations are possibly diminished by the “randomiza-
tion” of nonsystematic errors that results when massive
numbers of observations are statistically analyzed.47 In
addition, the population defined as Hispanic by state-
wide databases is heterogeneous in many ways. Our
results may not fully reflect the diverse experience of this
population and may neglect important differences within
this group. Nonetheless, important common cultural
and socioeconomic factors support the use of this broad
definition.
CONCLUSION
Hispanic patients underwent significantly fewer pro-
cedures for AAA and carotid artery disease than did white
non-Hispanics but tended to present with more ad-
vanced disease at the time of treatment. Lower extremity
revascularization procedures were more likely to be for
JOURNAL OF VASCULAR SURGERY
Volume 46, Number 5 Morrissey et al 977limb-threatening ischemia in Hispanics than white non-
Hispanics and were more likely to result in amputation.
The reasons for such disparities are likely to be multifac-
torial and require further investigation.
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